Medical Diagnostics & Research Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Medical Diagnostics & Research
Aclaris Therapeutics Inc (ACRS) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights and Financial Health
Exploring the robust financial positioning and strategic developments of Aclaris Therapeutics in the first quarter of 2024. May 08, 2024
GuruFocus Research Medical Diagnostics & Research
Veracyte Inc (VCYT) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with Revenue Surge and Record Testing Volumes
Explore key insights from Veracyte's Q1 2024 earnings, including significant revenue growth, testing volume records, and strategic expansions. May 08, 2024
GuruFocus Research Medical Diagnostics & Research
Myriad Genetics Inc (MYGN) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Robust Revenue Growth and Strategic Realignments
Explore key insights from Myriad Genetics' Q1 2024 earnings, featuring significant revenue increases and strategic initiatives aimed at enhancing market position. May 08, 2024
GuruFocus Research Medical Diagnostics & Research
iSpecimen Inc (ISPC) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and Seizing Opportunities
Despite a dip in revenue and specimen count, iSpecimen Inc (ISPC) showcases strategic adjustments and promising initiatives for sustainable growth. May 08, 2024
GuruFocus Research Medical Diagnostics & Research
Neuronetics Inc (STIM) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth Amidst Challenges
Despite cybersecurity setbacks, Neuronetics reports robust revenue growth and strategic expansions, setting a positive outlook for 2024. May 08, 2024